Finance

Lists
RGT:ASX
Argent BioPharma Ltd
A$0.030
0.00%
(0.00) 1D
Sep 30, 4:00:00 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for RGT...
Open
A$0.03
High
A$0.03
Low
A$0.03
Mkt. cap
3.50M
Avg. vol.
157.64K
Volume
64.32K
52-wk high
A$0.11
52-wk low
A$0.03
EPS
-A$0.09
Shares outstanding
116.61M
Open
A$0.03
High
A$0.03
Low
A$0.03
Mkt. cap
3.50M
Avg. vol.
157.64K
Volume
64.32K
52-wk high
A$0.11
52-wk low
A$0.03
EPS
-A$0.09
Shares outstanding
116.61M
News stories
From web sources and news partners
About Argent BioPharma Ltd
CEORoby Zomer
Employees-
Founded2005
Headquarters-
SectorPharmaceutical industry
Websiteargentbiopharma.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
85.75K
85.75K
-5.16K
-5.16K
Cost of goods sold
103.51K
103.51K
-3.11K
-3.11K
Cost of revenue
103.51K
103.51K
-3.11K
-3.11K
Research and development expenses
201.15K
201.15K
43.94K
43.94K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.26M
1.26M
2.17M
2.17M
Operating expense
1.47M
1.47M
2.23M
2.23M
Total operating expenses
1.58M
1.58M
2.23M
2.23M
Operating income
-1.49M
-1.49M
-2.23M
-2.23M
Other non operating income
66.88K
66.88K
-367.79K
-367.79K
EBT including unusual items
-1.47M
-1.47M
-2.39M
-2.39M
EBT excluding unusual items
-1.44M
-1.44M
-2.39M
-2.39M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
13.05K
13.05K
4.24K
4.24K
Net income
-1.47M
-1.47M
-2.39M
-2.39M
Net profit margin
-1,711.52%
-1,711.52%
46,304.27%
46,304.27%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-16.75K
-16.75K
-102.00
-102.00
Net interest expenses
-16.75K
-16.75K
-102.00
-102.00
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.47M
-1.47M
-2.23M
-2.23M
Gain or loss from assets sale
-
-
12.69K
12.69K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps